Birdwatch Note
2024-09-21 13:06:45 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
誤解を招く投稿です 本治験は A群:ワクチン→3か月程観察①A→プラセボ→4か月程観察②A B群:プラセボ→3か月間観察①B→ワクチン→4か月程観察②B の4観察期間で ①A死亡5(コロナ死1 ①B死亡16(コロナ死9 ②A死亡9 ②B死亡4 です(各群八千人程) 下記pdf28p https://web.archive.org/web/20240120232711/https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_2.pdf#page=28 即ち有効性評価対象の①部分でプラセボが3倍以上死亡しました また本治験は17%の高齢者を含み https://www.nature.com/articles/s41467-024-47905-1/tables/1 11か月で八千人が18人死亡(①A②A②Bの和)はベトナムの年間死亡率の３分の１程で https://data.worldbank.org/indicator/SP.DYN.CDRT.IN?locations=VN どの死亡も接種の因果関係は否定されています(上記pdf28P またこれは公開資料です
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1837465510654758931
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1837478575773200629
- noteId - 1837478575773200629
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1726924005821
- tweetId - 1837465510654758931
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 誤解を招く投稿です 本治験は A群:ワクチン→3か月程観察①A→プラセボ→4か月程観察②A B群:プラセボ→3か月間観察①B→ワクチン→4か月程観察②B の4観察期間で ①A死亡5(コロナ死1 ①B死亡16(コロナ死9 ②A死亡9 ②B死亡4 です(各群八千人程) 下記pdf28p https://web.archive.org/web/20240120232711/https://www.pmda.go.jp/drugs/2023/P20231122002/780009000_30500AMX00282_A100_2.pdf#page=28 即ち有効性評価対象の①部分でプラセボが3倍以上死亡しました また本治験は17%の高齢者を含み https://www.nature.com/articles/s41467-024-47905-1/tables/1 11か月で八千人が18人死亡(①A②A②Bの和)はベトナムの年間死亡率の３分の１程で https://data.worldbank.org/indicator/SP.DYN.CDRT.IN?locations=VN どの死亡も接種の因果関係は否定されています(上記pdf28P またこれは公開資料です
Note Ratings
| rated at | rated by | |
| 2024-09-26 04:21:07 -0500 | Rating Details | |
| 2024-09-23 01:08:50 -0500 | Rating Details | |
| 2024-09-22 07:15:00 -0500 | Rating Details | |
| 2024-09-22 05:52:24 -0500 | Rating Details | |
| 2024-09-22 05:21:52 -0500 | Rating Details | |
| 2024-09-22 01:57:13 -0500 | Rating Details | |
| 2024-09-22 01:33:28 -0500 | Rating Details | |
| 2024-09-22 01:25:06 -0500 | Rating Details | |
| 2024-09-22 00:38:37 -0500 | Rating Details | |
| 2024-09-22 00:17:48 -0500 | Rating Details | |
| 2024-09-22 00:16:49 -0500 | Rating Details | |
| 2024-09-22 00:11:10 -0500 | Rating Details | |
| 2024-09-21 23:24:05 -0500 | Rating Details | |
| 2024-09-21 23:14:15 -0500 | Rating Details | |
| 2024-09-21 21:20:43 -0500 | Rating Details | |
| 2024-09-21 20:56:50 -0500 | Rating Details | |
| 2024-09-21 20:37:24 -0500 | Rating Details | |
| 2024-09-21 20:12:25 -0500 | Rating Details | |
| 2024-09-21 20:05:02 -0500 | Rating Details | |
| 2024-09-21 19:49:37 -0500 | Rating Details | |
| 2024-09-21 19:37:56 -0500 | Rating Details | |
| 2024-09-21 19:04:50 -0500 | Rating Details | |
| 2024-09-21 18:40:56 -0500 | Rating Details | |
| 2024-09-21 18:37:59 -0500 | Rating Details | |
| 2024-09-21 17:57:32 -0500 | Rating Details | |
| 2024-09-21 17:41:20 -0500 | Rating Details | |
| 2024-09-21 17:22:09 -0500 | Rating Details | |
| 2024-09-21 17:19:29 -0500 | Rating Details | |
| 2024-09-21 17:18:21 -0500 | Rating Details | |
| 2024-09-21 17:09:40 -0500 | Rating Details | |
| 2024-09-21 16:56:05 -0500 | Rating Details | |
| 2024-09-21 16:16:12 -0500 | Rating Details | |
| 2024-09-21 16:16:06 -0500 | Rating Details | |
| 2024-09-21 15:11:35 -0500 | Rating Details | |
| 2024-09-21 14:53:38 -0500 | Rating Details | |
| 2024-09-21 14:39:15 -0500 | Rating Details | |
| 2024-09-21 14:15:38 -0500 | Rating Details | |
| 2024-09-21 13:47:11 -0500 | Rating Details | |
| 2024-09-21 12:57:25 -0500 | Rating Details | |
| 2024-09-21 12:36:14 -0500 | Rating Details | |
| 2024-09-21 12:16:01 -0500 | Rating Details | |
| 2024-09-21 11:31:22 -0500 | Rating Details | |
| 2024-09-21 11:21:41 -0500 | Rating Details | |
| 2024-09-21 10:39:23 -0500 | Rating Details | |
| 2024-09-21 10:29:54 -0500 | Rating Details | |
| 2024-09-21 10:13:03 -0500 | Rating Details | |
| 2024-09-21 10:11:58 -0500 | Rating Details | |
| 2024-09-21 10:11:45 -0500 | Rating Details | |
| 2024-09-21 09:39:52 -0500 | Rating Details | |
| 2024-09-21 09:36:15 -0500 | Rating Details | |
| 2024-09-21 09:18:28 -0500 | Rating Details | |
| 2024-09-21 09:11:20 -0500 | Rating Details | |
| 2024-09-21 09:03:55 -0500 | Rating Details | |
| 2024-09-21 09:02:11 -0500 | Rating Details | |
| 2024-09-21 08:59:12 -0500 | Rating Details | |
| 2024-09-21 08:56:59 -0500 | Rating Details | |
| 2024-09-21 08:37:40 -0500 | Rating Details | |
| 2024-09-21 08:36:38 -0500 | Rating Details | |
| 2024-09-21 08:35:25 -0500 | Rating Details | |
| 2024-09-21 08:30:38 -0500 | Rating Details | |
| 2024-09-21 08:22:56 -0500 | Rating Details | |
| 2024-09-21 08:21:45 -0500 | Rating Details | |
| 2024-09-21 08:18:36 -0500 | Rating Details |